Galectin Therapeutics Inc (GALT)

Date: O: H: L: C: Vol:

Finanzdaten der Galectin Therapeutics Inc-Aktie (GALT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	2.33%3.98	4.08	3.37	4.20	4.63
Research and Development	4.30%2.14	2.23	1.93	2.61	3.26
Operating Income/Loss	2.33%-3.98	-4.08	-3.37	-4.20	-4.63
Nonoperating Income/Loss	429.51%-5.13	-0.97	-2.14	-3.99	-2.90
	80.60%-9.11	-5.05	-5.50	-8.18	-7.52
Attributable To Parent	80.60%-9.11	-5.05	-5.50	-8.18	-7.52
Available To Common Stockholders, Basic	81.07%-9.18	-5.07	-5.56	-8.22	-7.58
Preferred Stock Dividends And Other Adjustments	195.24%0.06	0.02	0.06	0.04	0.06
Basic Average Shares	0.14%65.88	65.78	-	64.21	63.45
Diluted Average Shares	0.14%65.88	65.78	-	64.21	63.45
Basic Earnings Per Share	75.00%-0.14	-0.08	-	-0.13	-0.12
Diluted Earnings Per Share	75.00%-0.14	-0.08	-	-0.13	-0.12